Anticoagulant therapy in human renal disease.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects; D002648:Child; D004195:Disease Models, Animal; D005078:Exchange Transfusion, Whole Blood; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy*; D010956:Plasmapheresis; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy; D011817:Rabbits; D012790:Shwartzman Phenomenon / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin